The DOI matches its Crossref record.
Coronary restenosis elimination with a sirolimus eluting stent; First European human experience with 6-month angiographic and intravascular ultrasonic follow-up
Open accessAbstract
AIMS: Coronary stenting is limited by a 10%-60% restenosis rate due to neointimal hyperplasia. Sirolimus is a macrocyclic lactone agent that interacts with cell-cycle regulating proteins and inhibits cell division between phases G1 and S1. The hypothesis tested in this study is that local delivery of sirolimus with an eluting stent can prevent restenosis. METHODS AND RESULTS: Fifteen patients were treated with 18 mm sirolimus eluting BX VELOCITY stents. Quantitative angiography and three-dimensional quantitative intravascular ultrasound were performed at implantation and at the 6 months follow-up. All stent implantations were successful. One patient died on day 2, of cerebral haemorrhage and one patient suffered a subacute stent occlusion due to edge dissection (re-PTCA, CKMB 42). At 9 months no further adverse events had occurred and all patients were angina free. Quantitative coronary angiography revealed no change in minimal lumen diameter and percent diameter stenosis and hence no in-lesion or in-stent restenosis. Quantitative intravascular ultrasound showed that intimal hyperplasia volume and percent obstruction volume at follow-up were negligible at 5.3 mm(3)and 1.8%, respectively. No edge effect was observed in the segments proximal and distal to the stents. CONCLUSION: Implantation of a sirolimus-eluting stent seems to effectively prevent intimal hyperplasia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224
Serruys, P. W., Kutryk, M. J. B., & Ong, A. T. L. (2006) · New England Journal of Medicine · doi:10.1056/nejmra051091 · Cited by 762
Ormiston, J. A., Serruys, P. W., Regar, E., Dudek, D., Thuesen, L., Webster, M. W., Onuma, Y., Garcia-Garcia, H. M., McGreevy, R., & Veldhof, S. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60415-8 · Cited by 712
Hedman, M., Hartikainen, J., Syvänne, M., Stjernvall, J., Hedman, A., Kivelä, A., Vanninen, E., Mussalo, H., Kauppila, E., Simula, S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000070540.80780.92 · Cited by 537
Holmes, D. R., Leon, M. B., Moses, J. W., Popma, J. J., Cutlip, D., Fitzgerald, P. J., Brown, C., Fischell, T., Wong, S. C., Midei, M., et al. (2004) · Circulation · doi:10.1161/01.cir.0000112572.57794.22 · Cited by 515
Garg, S., & Serruys, P. W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.007 · Cited by 501
A Paclitaxel-Eluting Stent for the Prevention of Coronary Restenosis
Park, S.-J., Shim, W. H., Ho, D. S., Raizner, A. E., Park, S.-W., Hong, M.-K., Lee, C. W., Choi, D., Jang, Y., Lam, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021007 · Cited by 456
Onuma, Y., & Serruys, P. W. (2011) · Circulation · doi:10.1161/circulationaha.110.971606 · Cited by 434
Serruys, P. W., Garcia-Garcia, H. M., & Onuma, Y. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr384 · Cited by 303
Lanza, G. M., Yu, X., Winter, P. M., Abendschein, D. R., Karukstis, K. K., Scott, M. J., Chinen, L. K., Fuhrhop, R. W., Scherrer, D. E., & Wickline, S. A. (2002) · Circulation · doi:10.1161/01.cir.0000044020.27990.32 · Cited by 287
Suppression of scarring in peripheral nerve implants by drug elution
FitzGerald, J. J. (2016) · Journal of Neural Engineering · doi:10.1088/1741-2560/13/2/026006 · Cited by 27
Metadata
- Authors
- Rensing, B.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-11-15
- Volume
- 22
- Issue
- 22
- Pages
- 2125-2130
- ISSN
- 0195-668X (ISSN-L)
- OpenAlex
- W2165941336
- Cited by
- 183
- References
- 0
- FWCI
- 21.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.